Tom Zirpoli: The US is losing Trump’s tariff wars | COMMENTARY

The EU-India free-trade agreement and recent Canada–China and Canada–EU trade moves threaten U.S. export markets across autos, aircraft, electronics, petroleum, machinery, pharmaceuticals and agricultural goods; the EU economy is roughly $20 trillion and U.S.–EU trade totaled about $1.5 trillion in 2024 with U.S. exports to the EU near $370 billion. U.S. trade flows with Canada (~$909 billion cross-border annually, ~$440 billion in U.S. exports) and a rising U.S. trade deficit ($918bn in 2024 to $1.02tn in 2025) underscore exposure, while Trump’s new India tariff deal reportedly cuts average U.S. tariffs on Indian imports to 18% from prior levels (~34.5% cited) conditional on oil purchases. Material sectoral impacts are plausible (soybeans, wine/spirits—declines to Canada of 91% and 56% since 2024, respectively, cited), implying continued policy-driven demand shifts and heightened trade-risk for U.S. exporters.

Analysis

Market structure: The EU–India FTA and parallel China–Canada deals shift durable goods and low‑margin manufacturing demand away from U.S. exporters (autos, steel, textiles, some pharma) toward Indian/EU suppliers, compressing U.S. export pricing power. Direct winners: Indian exporters and EU manufacturers, Asian logistics/ship operators and select global pharma (AZN) gaining scale; direct losers: U.S. agricultural exporters, heavy machinery (CAT, DE), and beverage exporters (US wine/spirits) facing secular share loss. FX and rates: incremental downward pressure on USD over 12–36 months if U.S. loses export volumes >3–5%, while short‑term safe‑haven demand could keep yields volatile.

Risk assessment: Tail risks include accelerated bloc formation (EU–India plus China–Canada) leading to tariff corridor fragmentation and a permanent 5–10% revenue hit for exposed U.S. exporters; regulatory retaliation or secondary sanctions are low probability but high impact. Immediate (days): pockets of FX and commodity volatility; short (weeks–months): corporate procurement shifts and orderbook revisions; long (quarters–years): structural market‑share redistribution. Hidden dependencies: contractual supply‑chain lead times (6–18 months), export finance changes, and government procurement rules that can lock flows.

Trade implications: Tactical longs: India exposure (INDA or large-cap exporters) and Europe export champions; tactical shorts: U.S. exporters with >20% revenue to EU/Canada (CAT, ADM). Options: buy 3–6 month puts on CAT and ADM sized to 0.5–1% portfolio; buy 9–12 month call spreads on INDA or AZN to capture re‑rating. Rotate out of US industrials/agri exporters into India/EU exporters over 4–12 weeks as FTAs are ratified.

Contrarian angles: Consensus understates near‑term re‑shoring costs that will create US domestic capex opportunities (semis, defense, advanced manufacturing) — a potential 12–36 month opportunity to buy select US capex suppliers as governments subsidize reshoring. Market may be overpricing permanent loss: if U.S. trade policy normalizes or FTAs lack implementation, many exporters can recover 2–6% revenues; watch export order books and country trade flows for reversal signals.

Key Decisions for Investors

• Establish a 2–3% long position in INDA (iShares MSCI India ETF) with a 12–18 month horizon to capture tariff‑induced export share gains; trim/exit if INDA rises 20% or if EU–India FTA implementation is delayed >90 days post‑signing.
• Initiate a 1% tactical short on CAT (or equivalent industrial exposure) via 3‑month-to-6‑month 5% OTM put purchases (or put spread) sized to 1% portfolio risk; target 10–20% downside, stop‑loss if CAT issues >=2% positive order growth guidance or share recovers 15%.
• Overweight AZN by 1–2% (buy shares or 6–9 month call spread) to play pharma investment flows into China/EU; take profits on 15% upside and cut at 8% adverse move.
• Buy 3–6 month puts on ADM sized to 0.5–1% portfolio (or short soybean futures equivalent) anticipating sustained loss of Chinese/Canadian demand; close position if U.S. export volumes to Canada/EU drop less than 3% YoY or if a new procurement agreement reverses flows.
• Reallocate 2–4% from US export‑heavy Industrials/Staples into European exporter ETFs (VGK) or selective manufacturing ETFs within 30–60 days after FTA ratification; re‑assess after one fiscal quarter of company order‑book updates.